{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:01:59Z","timestamp":1790128919643,"version":"4.0.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"abstract":"<jats:p>Although compartmentalization of the eye seems to promote its experimental manipulation, drug penetration to its posterior part is severely limited by hard barriers thus hindering drug development for eye diseases. In particular, angiogenesis-related retinal diseases share common mechanisms and are responsible for the majority of cases of blindness. Their prevalence is globally increasing mostly because of the increased incidence of systemic pathologies in the adult. Despite the number of preclinical findings demonstrating the efficacy of novel treatments, therapy of retinal neovascular diseases still remains confined to intravitreal anti-vascular endothelial growth factor treatments with some extension to anti-inflammatory therapy. In the <jats:italic>mare magnum<\/jats:italic> of preclinical findings aimed to develop novel avenues for future therapies, most compounds, despite their efficacy in experimental models, do not seem to meet the criteria for their therapeutic application. In particular, the groove between preclinical findings and their clinical application increases instead of decreasing and the attempt to bridging the gap between them creates intense frustration and a sense of defeat. In this complex scenario, we will discuss here the role that overactivation of the sympathetic system plays in retinal vessel proliferation in response to hypoxia using the oxygen-induced retinopathy (OIR) model. The potential application of the beta-adrenoceptor (\u03b2-AR) blockade with propranolol to the treatment of retinopathy of prematurity will be also discussed in light of preclinical findings in the OIR model and clinical trials using propranolol in preterm infants either <jats:italic>per os<\/jats:italic> or as eye drops.<\/jats:p>","DOI":"10.3389\/fphys.2024.1408605","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:10:23Z","timestamp":1718255423000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["A promising case of preclinical-clinical translation: \u03b2-adrenoceptor blockade from the oxygen-induced retinopathy model to retinopathy of prematurity"],"prefix":"10.3389","volume":"15","author":[{"given":"Maurizio","family":"Cammalleri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Dal Monte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40123-022-00456-4","article-title":"The use of sustained release intravitreal steroid implants in non-infectious uveitis affecting the posterior segment of the eye","volume":"11","author":"Abdulla","year":"2022","journal-title":"Ophthalmol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.phrs.2009.05.005","article-title":"Propranolol adrenergic blockade inhibits human brain endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion","volume":"60","author":"Annabi","year":"2009","journal-title":"Pharmacol. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.3390\/life13051098","article-title":"Update on the management of diabetic retinopathy: anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative retinopathy","volume":"13","author":"Bahr","year":"2023","journal-title":"Life (Basel)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/path.2611","article-title":"M\u00fcller cell-derived VEGF is a significant contributor to retinal neovascularization","volume":"219","author":"Bai","year":"2009","journal-title":"J. Pathol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1515\/jpm-2015-0357","article-title":"Oral propranolol in early stages of retinopathy of prematurity","volume":"44","author":"Bancalari","year":"2016","journal-title":"J. Perinat. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1152\/ajpregu.1998.274.1.R19","article-title":"CO2 asphyxia increases plasma norepinephrine in rats via sympathetic nerves","volume":"274","author":"Borovsky","year":"1998","journal-title":"Am. J. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1080\/10715762.2019.1697809","article-title":"The role of pigment epithelium-derived factor in protecting against cellular stress","volume":"53","author":"Brook","year":"2019","journal-title":"Free Radic. Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fncel.2017.00395","article-title":"The beta adrenergic receptor blocker propranolol counteracts retinal dysfunction in a mouse model of oxygen induced retinopathy: restoring the balance between apoptosis and autophagy","volume":"11","author":"Cammalleri","year":"2017","journal-title":"Front. Cell Neurosci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.preteyeres.2014.06.001","article-title":"The \u03b2-adrenergic system as a possible new target for pharmacologic treatment of neovascular retinal diseases","volume":"42","author":"Casini","year":"2014","journal-title":"Prog. Retin Eye Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"key":"B11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3390\/jcm10050981","article-title":"Inflammatory complications of intravitreal anti-VEGF injections","volume":"10","author":"Cox","year":"2021","journal-title":"J. Clin. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.3390\/ijms23084217","article-title":"The role of propranolol as a repurposed drug in rare vascular diseases","volume":"23","author":"Cuesta","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajo.2023.04.014","article-title":"Electroretinographic responses in retinopathy of prematurity treated using intravitreal bevacizumab or laser","volume":"252","author":"Curran","year":"2023","journal-title":"Am. J. Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"B15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.exer.2013.03.013","article-title":"Eye drop propranolol administration promotes the recovery of oxygen-induced retinopathy in mice","volume":"111","author":"Dal Monte","year":"2013","journal-title":"Exp. Eye Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD000501","DOI":"10.1002\/14651858.CD000501","article-title":"Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants","author":"Darlow","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e91877","DOI":"10.1371\/journal.pone.0091877","article-title":"Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gi\u03b1-coupled \u03b22-adrenoceptor signaling pathway","volume":"9","author":"Davel","year":"2014","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archinternmed.2011.131","article-title":"Treatment with \u03b2-blockers and reduced disease progression in patients with thick melanoma","volume":"171","author":"De Giorgi","year":"2011","journal-title":"Arch. Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/nu12010204","article-title":"Dietary supplements: which place between food and drugs?","volume":"12","author":"F\u00e9art","year":"2020","journal-title":"Nutrients"},{"key":"B20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/pr.2016.230","article-title":"Propranolol 0.1% eye micro-drops in newborns with retinopathy of prematurity: a pilot clinical trial","volume":"81","author":"Filippi","year":"2017","journal-title":"Pediatr. Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.jpeds.2013.07.049","article-title":"Oral propranolol for retinopathy of prematurity: risks, safety concerns, and perspectives","volume":"163","author":"Filippi","year":"2013","journal-title":"J. Pediatr."},{"key":"B22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3389\/fped.2019.00180","article-title":"Propranolol 0.2% eye micro-drops for retinopathy of prematurity: a prospective phase IIB study","volume":"7","author":"Filippi","year":"2019","journal-title":"Front. Pediatr."},{"key":"B23","unstructured":"Dietary supplement2021"},{"key":"B24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.20517\/jca.2022.10","article-title":"Why animal model studies are lost in translation","volume":"2","author":"Frangogiannis","year":"2022","journal-title":"J. Cardiovasc Aging"},{"key":"B25","doi-asserted-by":"publisher","first-page":"12409","DOI":"10.1038\/s41598-020-68488-z","article-title":"VEGF is an autocrine\/paracrine neuroprotective factor for injured retinal ganglion neurons","volume":"10","author":"Froger","year":"2020","journal-title":"Sci. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1161\/CIRCRESAHA.111.300152","article-title":"\u03b22-Adrenergic receptor stimulation improves endothelial progenitor cell-mediated ischemic neoangiogenesis","volume":"112","author":"Galasso","year":"2013","journal-title":"Circ. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/978-1-4939-3628-1_22","article-title":"Models of oxygen induced retinopathy in rodents","volume":"1430","author":"Gammons","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"44732","DOI":"10.18632\/oncotarget.17267","article-title":"Catecholamines facilitate VEGF-dependent angiogenesis via \u03b22-adrenoceptor-induced Epac1 and PKA activation","volume":"8","author":"Garg","year":"2017","journal-title":"Oncotarget"},{"key":"B29","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13052-020-00837-0","article-title":"Oral vitamin A supplementation for ROP prevention in VLBW preterm infants","volume":"46","author":"Garofoli","year":"2020","journal-title":"Ital. J. Pediatr."},{"key":"B30","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","article-title":"Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections","volume":"24","author":"Gonz\u00e1lez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.3390\/ph16081140","article-title":"Intravitreal anti-vascular endothelial growth factor therapies for retinal disorders","volume":"16","author":"Hang","year":"2023","journal-title":"Pharm. (Basel)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamapediatrics.2020.5653","article-title":"Effect of enteral lipid supplement on severe retinopathy of prematurity: a randomized clinical trial","volume":"175","author":"Hellstr\u00f6m","year":"2021","journal-title":"JAMA Pediatr."},{"key":"B33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3928\/23258160-20171215-05","article-title":"Propranolol for proliferative diabetic retinopathy","volume":"49","author":"Hendrick","year":"2018","journal-title":"Ophthalmic Surg. Lasers Imaging Retina"},{"key":"B34","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s13287-021-02546-9","article-title":"Cell-based therapies for retinal diseases: a review of clinical trials and direct to consumer \"cell therapy\" clinics","volume":"12","author":"Hinkle","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"115535","DOI":"10.1016\/j.ejmech.2023.115535","article-title":"Research progress of VEGFR small molecule inhibitors in ocular neovascular diseases","volume":"257","author":"Jiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2174\/0115733998274599231109034741","article-title":"Diabetic retinopathy leading to blindness- A review","volume":"24","author":"Kaur","year":"2024","journal-title":"Curr. Diabetes Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13287-016-0335-y","article-title":"Overexpression of the \u03b22AR gene improves function and re-endothelialization capacity of EPCs after arterial injury in nude mice","volume":"7","author":"Ke","year":"2016","journal-title":"Stem Cell Res. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12967-023-03937-7","article-title":"Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration","volume":"21","author":"Khachigian","year":"2023","journal-title":"J. Transl. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/pharmaceutics13010108","article-title":"Ocular drug delivery to the retina: current innovations and future perspectives","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e15619","DOI":"10.15252\/emmm.202115619","article-title":"The onset of PI3K-related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib","volume":"14","author":"Kobialka","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/IAE.0000000000002059","article-title":"Systemic beta-blockers and risk of progression to neovascular age-related macular degeneration","volume":"39","author":"Kolomeyer","year":"2019","journal-title":"Retina"},{"key":"B42","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.3390\/cancers13194987","article-title":"Mechanical aspects of angiogenesis","volume":"13","author":"Kretschmer","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1007\/s40123-023-00807-9","article-title":"Biomarkers for the progression of intermediate age-related macular degeneration","volume":"12","author":"Lad","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1001\/jamaophthalmol.2013.1476","article-title":"Attenuation of choroidal neovascularization by \u03b2(2)-adrenoreceptor antagonism","volume":"131","author":"Lavine","year":"2013","journal-title":"JAMA Ophthalmol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2302\/kjm.2021-0004-IR","article-title":"HIF inhibition therapy in ocular diseases","volume":"71","author":"Lee","year":"","journal-title":"Keio J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s12276-022-00785-1","article-title":"Flow goes forward and cells step backward: endothelial migration","volume":"54","author":"Lee","year":"","journal-title":"Exp. Mol. Med."},{"key":"B48","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/jcp.25483","article-title":"The \u03b22-adrenoceptor agonist terbutaline stimulates angiogenesis via Akt and ERK signaling","volume":"232","author":"Lemmens","year":"2017","journal-title":"J. Cell Physiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"20406223221140395","DOI":"10.1177\/20406223221140395","article-title":"Novel therapies for proliferative retinopathies","volume":"13","author":"Martinez-Alejo","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"780841","DOI":"10.3389\/fnins.2021.780841","article-title":"Blocking ocular sympathetic activity inhibits choroidal neovascularization","volume":"15","author":"Martinez-Camarillo","year":"2022","journal-title":"Front. Neurosci."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/j.1471-4159.2011.07530.x","article-title":"Antiangiogenic effects of \u03b22 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy","volume":"119","author":"Martini","year":"2011","journal-title":"J. Neurochem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/IAE.0b013e3182695ba0","article-title":"Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab","volume":"33","author":"Montero","year":"2013","journal-title":"Retina"},{"key":"B53","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ando.2020.03.012","article-title":"Adrenergic receptors and cardiovascular effects of catecholamines","volume":"82","author":"Motiejunaite","year":"2021","journal-title":"Ann. Endocrinol. Paris."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s00018-020-03664-y","article-title":"Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology","volume":"78","author":"M\u00fchleder","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"B55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2353\/ajpath.2007.061237","article-title":"Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury","volume":"171","author":"Nishijima","year":"2007","journal-title":"Am. J. Pathol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4103\/joco.joco_38_23","article-title":"An update on anti-vascular endothelial growth factor treatment for retinopathy of prematurity","volume":"35","author":"Nowroozzadeh","year":"2023","journal-title":"J. Curr. Ophthalmol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/2008-322X.180697","article-title":"Surgery for proliferative diabetic retinopathy: new tips and tricks","volume":"11","author":"Oellers","year":"2016","journal-title":"J. Ophthalmic Vis. Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/febs.16330","article-title":"The blood-retina barrier in health and disease","volume":"290","author":"O\u2019Leary","year":"2023","journal-title":"FEBS J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/pr.2014.108","article-title":"Pharmacokinetics and local safety profile of propranolol eye drops in rabbits","volume":"76","author":"Padrini","year":"2014","journal-title":"Pediatr. Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/MPH.0000000000002384","article-title":"Infantile hemangioma: a current review","volume":"44","author":"Pahl","year":"2022","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.3346\/jkms.2015.30.12.1828","article-title":"Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis","volume":"30","author":"Park","year":"2015","journal-title":"J. Korean Med. Sci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1322783","DOI":"10.3389\/fped.2024.1322783","article-title":"Propranolol: a new pharmacologic approach to counter retinopathy of prematurity progression","volume":"12","author":"Pascarella","year":"2024","journal-title":"Front. Pediatr."},{"key":"B63","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.1542\/peds.2012-0517","article-title":"Meta-analysis of LCPUFA supplementation of infant formula and visual acuity","volume":"131","author":"Qawasmi","year":"2013","journal-title":"Pediatrics"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.21037\/atm-20-6737","article-title":"Animal models of diabetic retinopathy","volume":"9","author":"Quiroz","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.2147\/OPTH.S374165","article-title":"A paradigm shift in the management approaches of proliferative diabetic retinopathy: role of anti-VEGF therapy","volume":"16","author":"Raman","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1167\/iovs.10-5536","article-title":"Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade","volume":"52","author":"Ristori","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.3390\/cells9122594","article-title":"The role of adrenoceptors in the retina","volume":"9","author":"Ruan","year":"2020","journal-title":"Cells"},{"key":"B69","doi-asserted-by":"publisher","first-page":"105115","DOI":"10.1016\/j.phrs.2020.105115","article-title":"Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy","volume":"161","author":"Rudraraju","year":"2020","journal-title":"Pharmacol. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3390\/medicina59071334","article-title":"Pharmacotherapy and nutritional supplements for neovascular eye diseases","volume":"59","author":"Rusciano","year":"2023","journal-title":"Med. Kaunas."},{"key":"B71","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.3390\/ijms23158529","article-title":"New aspects on the treatment of retinopathy of prematurity: currently available therapies and emerging novel therapeutics","volume":"23","author":"Ryu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.3390\/biomedicines11092445","article-title":"Neovascular progression and retinal dysfunction in the laser-induced choroidal neovascularization mouse model","volume":"11","author":"Salas","year":"2023","journal-title":"Biomedicines"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/apa.16850","article-title":"Treating infants with 0.2% propranolol eye micro-drops drastically reduced the progression of retinopathy of prematurity","volume":"112","author":"Scaramuzzo","year":"2023","journal-title":"Acta Paediatr."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa073679","article-title":"Long-term effects of caffeine therapy for apnea of prematurity","volume":"357","author":"Schmidt","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"17891","DOI":"10.1002\/cam4.6424","article-title":"\u03b22-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma","volume":"12","author":"Schuster","year":"2023","journal-title":"Cancer Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"e151109","DOI":"10.1172\/JCI151109","article-title":"Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma","volume":"132","author":"Seebauer","year":"2022","journal-title":"J. Clin. Invest."},{"key":"B77","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2023.11.012","article-title":"Effectiveness of propranolol in preventing severe retinopathy of prematurity: a comprehensive systematic review and meta-analysis","volume":"259","author":"Shafique","year":"2024","journal-title":"Am. J. Ophthalmol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.2174\/15665240113139990055","article-title":"\u03b22-AR-HIF-1\u03b1: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis","volume":"13","author":"Shan","year":"2013","journal-title":"Curr. Mol. Med."},{"key":"B79","first-page":"638","article-title":"Clinical findings associated with propranolol and fenofibrate on acute central serous chorioretinopathy","volume":"10","author":"Shao","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00441-014-1976-8","article-title":"\u03b2-Adrenergic receptor antagonists inhibit vasculogenesis of embryonic stem cells by downregulation of nitric oxide generation and interference with VEGF signalling","volume":"358","author":"Sharifpanah","year":"2014","journal-title":"Cell Tissue Res."},{"key":"B81","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.5.28","article-title":"Mechanisms of acquired resistance to anti-VEGF therapy for neovascular eye diseases","volume":"64","author":"Sharma","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fncel.2018.00288","article-title":"Inhibition of HIF-1\u03b1 reduced blood brain barrier damage by regulating MMP-2 and VEGF during acute cerebral ischemia","volume":"12","author":"Shen","year":"2018","journal-title":"Front. Cell Neurosci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40942-023-00460-1","article-title":"Intravitreal bevacizumab plus propranolol for neovascular age-related macular degeneration (the BEVALOL study): a phase I clinical trial","volume":"9","author":"Silva Tavares Neto","year":"2023","journal-title":"Int. J. Retina Vitr."},{"key":"B84","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Sim\u00f3","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"B85","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/tvst.12.11.24","article-title":"Safety and efficacy of adeno-associated viral gene therapy in patients with retinal degeneration: a systematic review and meta-analysis","volume":"12","author":"Sobh","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"8231","DOI":"10.3390\/ijms21218231","article-title":"Neurotransmitter modulation of carotid body germinal niche","volume":"21","author":"Sobrino","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41372-019-0503-x","article-title":"Oral propranolol in prevention of severe retinopathy of prematurity: a systematic review and meta-analysis","volume":"39","author":"Stritzke","year":"2019","journal-title":"J. Perinatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s41390-022-02211-8","article-title":"Propranolol ameliorates retinopathy of prematurity in mice by downregulating HIF-1\u03b1 via the PI3K\/Akt\/ERK pathway","volume":"93","author":"Su","year":"2023","journal-title":"Pediatr. Res."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1097\/IAE.0000000000002543","article-title":"Early vitamin a supplementation improves the outcome of retinopathy of prematurity in extremely preterm infants","volume":"40","author":"Sun","year":"2020","journal-title":"Retina"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/IAE.0000000000000603","article-title":"Effect of systemic beta-blockers, ace inhibitors, and angiotensin receptor blockers on development of choroidal neovascularization in patients with age-related macular degeneration","volume":"35","author":"Thomas","year":"2015","journal-title":"Retina"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1167\/iovs.13-13397","article-title":"Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy","volume":"55","author":"Tokunaga","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B93","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/IAE.0000000000001226","article-title":"Systemic beta-blockers in neovascular age-related macular degeneration","volume":"37","author":"Traband","year":"2017","journal-title":"Retina"},{"key":"B94","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3389\/fphar.2020.00873","article-title":"Exploration of oxygen-induced retinopathy model to discover new therapeutic drug targets in retinopathies","volume":"11","author":"V\u00e4h\u00e4tupa","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/biomedicines11061562","article-title":"Suppressing inflammation for the treatment of diabetic retinopathy and age-related macular degeneration: dazdotuftide as a potential new multitarget therapeutic candidate","volume":"11","author":"Vofo","year":"2023","journal-title":"Biomedicines"},{"key":"B96","doi-asserted-by":"publisher","first-page":"5276","DOI":"10.1167\/iovs.07-0129","article-title":"Role of beta-adrenergic receptors in inflammatory marker expression in M\u00fcller cells","volume":"48","author":"Walker","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","article-title":"Estimated research and development investment needed to bring a new medicine to market, 2009-2018","volume":"323","author":"Wouters","year":"2020","journal-title":"JAMA"},{"key":"B98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/vision6010006","article-title":"Ocular autonomic nervous system: an update from anatomy to physiological functions","volume":"6","author":"Wu","year":"2022","journal-title":"Vis. (Basel)."},{"key":"B99","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/biom11070936","article-title":"Ligands of adrenergic receptors: a structural point of view","volume":"11","author":"Wu","year":"2021","journal-title":"Biomolecules"},{"key":"B100","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/ijtm1030021","article-title":"A systematic review on the role of adrenergic receptors in angiogenesis regulation in health and disease","volume":"1","author":"Xanthopoulos","year":"2021","journal-title":"Intern J. Transl. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.2147\/DDDT.S383101","article-title":"Progress and challenges of anti-VEGF agents and their sustained-release strategies for retinal angiogenesis","volume":"16","author":"Xu","year":"2022","journal-title":"Drug Des. Devel Ther."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/CIRCRESAHA.118.314322","article-title":"\u03b22-Adrenergic stimulation compartmentalizes \u03b21 signaling into nanoscale local domains by targeting the C-terminus of \u03b21-adrenoceptors","volume":"124","author":"Yang","year":"2019","journal-title":"Circ. Res."},{"key":"B103","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/COPD.S222664","article-title":"GOLD in practice: chronic obstructive pulmonary disease treatment and management in the primary care setting","volume":"16","author":"Yawn","year":"2021","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1001\/jamaophthalmol.2023.0926","article-title":"Nationwide increase in the incidence of retinopathy of prematurity in the US-A growing problem?","volume":"141","author":"Ying","year":"2023","journal-title":"JAMA Ophthalmol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1007\/s10792-021-01737-w","article-title":"Impacts of intravitreal anti-VEGF therapy on retinal anatomy and neurophysiology in diabetic macular edema","volume":"41","author":"Yozgat","year":"2021","journal-title":"Int. Ophthalmol."},{"key":"B106","volume-title":"Laser principles in ophthalmology","author":"Zhang","year":"2023"}],"container-title":["Frontiers in Physiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2024.1408605\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T05:10:27Z","timestamp":1718255427000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphys.2024.1408605\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":106,"alternative-id":["10.3389\/fphys.2024.1408605"],"URL":"https:\/\/doi.org\/10.3389\/fphys.2024.1408605","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"article-number":"1408605"}}